CIK: 0001440771 · Show all filings
Period: Q3 2021 (← Previous) (Next →)
Filing Date: Nov 12, 2021
Total Value ($000): $219,763 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | AMRYT PHARMA PLC - SPNR ADR | 5,801,748 | $69,882 | 31.8% | $12.69 | — | SPONSORED ADS | 03217L106 |
| — | CTI BIOPHARMA CORP | 7,964,329 | $23,495 | 10.7% | $2.50 | — | COM | 12648L601 |
| — | ADAMAS PHARMACEUTICALS INC | 3,914,938 | $19,222 | 8.7% | $4.82 | — | COM | 00548A106 |
| GLPG | GALAPAGOS NV-SPON ADR | 244,205 | $12,848 | 5.8% | $52.61 | — | SPONS ADR | 36315X101 |
| OVID | OVID THERAPEUTICS INC | 3,252,892 | $10,930 | 5.0% | $3.45 | +5.8% | COM | 690469101 |
| — | CATALYST BIOSCIENCES INC | 2,635,014 | $10,830 | 4.9% | $4.78 | — | COM NEW | 14888D208 |
| — | STRONGBRIDGE BIOPHARMA PLC | 4,489,687 | $9,159 | 4.2% | $2.64 | — | SHS USD | G85347105 |
| — | APOLLO ENDOSURGERY INC | 912,125 | $8,264 | 3.8% | $4.82 | — | COM | 03767D108 |
| — | AFFIMED NV | 1,161,466 | $7,178 | 3.3% | $6.74 | — | COM | N01045108 |
| — | GAMIDA CELL LTD | 1,724,201 | $6,759 | 3.1% | $4.84 | — | SHS | M47364100 |
| XGN | EXAGEN INC | 390,637 | $5,313 | 2.4% | $15.26 | -12.9% | COM | 30068X103 |
| CELC | CELCUITY INC | 294,692 | $5,304 | 2.4% | $20.31 | +4.4% | COM | 15102K100 |
| — | YUMANITY THERAPEUTICS INC | 481,692 | $4,971 | 2.3% | $15.79 | — | COM | 98872L102 |
| ATYR | ATYR PHARMA INC | 410,535 | $3,728 | 1.7% | $5.98 | 0.0% | COM NEW | 002120202 |
| KALV | KALVISTA PHARMACEUTICALS INC | 200,000 | $3,490 | 1.6% | $26.28 | -22.9% | COM | 483497103 |
| — | SYNLOGIC INC | 1,000,000 | $3,050 | 1.4% | $3.05 | — | COM | 87166L100 |
| — | ANGION BIOMEDICA CORP | 280,183 | $2,737 | 1.2% | $14.79 | — | COM | 03476J107 |
| EOLS | EVOLUS INC | 300,000 | $2,286 | 1.0% | $10.34 | 0.0% | COM | 30052C107 |
| — | AVALO THERAPEUTICS INC | 850,000 | $1,853 | 0.8% | $2.18 | — | COM | 05338F108 |
| — | CIDARA THERAPEUTICS INC | 782,817 | $1,754 | 0.8% | $2.02 | — | COM | 171757107 |
| XOMA | XOMA CORP | 68,542 | $1,696 | 0.8% | $20.24 | +45.5% | COM NEW | 98419J206 |
| — | LEAP THERAPEUTICS INC | 250,000 | $1,003 | 0.5% | $4.01 | — | COM | 52187K101 |
| — | ANTARES PHARMA INC | 264,100 | $961 | 0.4% | $3.64 | — | COM | 036642106 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 80,537 | $839 | 0.4% | $11.25 | -15.2% | COM NEW | 30233G209 |
| DMAC | DIAMEDICA THERAPEUTICS INC | 165,775 | $665 | 0.3% | $4.96 | -22.8% | COM NEW | 25253X207 |
| — | CONFORMIS INC | 486,982 | $648 | 0.3% | $1.04 | — | COM | 20717E101 |
| — | NEUBASE THERAPEUTICS INC | 109,742 | $396 | 0.2% | $3.94 | — | COM | 64132K102 |
| IMUX | IMMUNIC INC | 22,409 | $198 | 0.1% | $9.84 | 0.0% | COM | 4525EP101 |
| — | CONTRAFECT CORP | 34,413 | $139 | 0.1% | $4.80 | — | COM NEW | 212326300 |
| — | SEASPINE HOLDINGS CORP | 8,349 | $131 | 0.1% | $15.69 | — | COM | 81255T108 |
| SCYX | SCYNEXIS INC | 6,327 | $34 | 0.0% | $6.57 | -0.3% | COM NEW | 811292200 |